Scroll through important milestones and highlights from our history, from 2009 until today.
This year Alvogen was founded on the strong foundation of Norwich Pharmaceutical services, with a 130-year history.
International expansion started. Foundation laid in major fields of operation.
International expansion continues. First products sold in the US market.
Alvogen enters the APAC region through strategic acquisitions. Biosimilar partnership signed with Hospira.
Alvogen recognized for a dynamic growth in the US market and further steps taken in the development of the APAC platform.
Biosimilar platform strengthened with new monoclonal antibodies launched in the CEE region. Alvogen aquires Korean Dream pharma.
Strategic launches, prestigious consortium of new investor on board and Asian operations strengthened.
Business expansion, Alvogen attracts intrest by Harvard business school and an opening of a state-of-the-art biosimilar facility.
Successful events and strategic product launches.